Eden Research plc
Eden Research plc is an AIM-quoted UK biopesticide company developing terpene-based crop protection products and Sustaine, a patented plastic-free yeast-cell microencapsulation technology, distributed globally through agrochemical partners.
- Company typePublic
- Founded2012
- HeadquartersCirencester, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Eden Research plc does
Eden Research plc is an AIM-quoted UK biotechnology company (ticker EDEN) that develops and commercialises biopesticide products and a proprietary natural microencapsulation technology for sustainable agriculture, animal health and consumer applications. The company's core technology platform, Sustaine, uses yeast-cell-derived hollow particles to encapsulate and deliver controlled slow-release doses of terpene-based active ingredients (thymol, eugenol and geraniol — three EU-approved naturally-derived substances), overcoming the historical volatility, phytotoxicity and solubility problems that have limited terpene use in crop protection. Sustaine is plastic-free and forms the basis of Eden's commercial product portfolio, which includes Mevalone (a biofungicide for Botrytis and powdery mildew, sold under various brand names such as 3logy, Araw, Novellus and Hawk across territories), Cedroz (a bio-nematicide for root-knot nematodes distributed by Eastman Chemical), Novellus+ (an enhanced Mevalone formulation), and Ecovelex (a bird-repellent maize seed treatment).
Eden operates an asset-light, partner-led commercialisation model. It holds no manufacturing of its own, relying instead on exclusive distribution agreements with major agrochemical incumbents — Sipcam-Oxon (12 countries, 9.9% equity holder), Eastman Chemical (29 countries for Cedroz), Syngenta (EU/UK ornamental crops from December 2025), and regional specialists such as SumiAgro, Andermatt Kenya, Advan Mexico and K&N Efthymiadis — together with licensing partners such as TerpeneTech (associate company, consumer and animal health) and Daymsa. Revenue is generated from product sales (which doubled to £1.6m in 2018), royalties and milestone payments from licensees, and upfront fees from data access licences to EU regulatory dossiers. End customers are primarily SMB growers and vintners across more than 40 countries, with cumulative IP investment of over £14m and a granted patent portfolio of 78 patents supporting the underlying technology and product franchises.
Eden Research plc firmographics
Firmographics- Name
- Eden Research plc
- Legal name
- Eden Research plc
- Website
- https://edenresearch.com
- Company type
- Public
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Eden Research plc is an AIM-quoted UK biopesticide company developing terpene-based crop protection products and Sustaine, a patented plastic-free yeast-cell microencapsulation technology, distributed globally through agrochemical partners.
- Ownership category
- akta.pro rank
Eden Research plc industry classification
Industry- Product category
- Biopesticides and Crop Protection
- NAICS
- Pesticide and Other Agricultural Chemical Manufacturing (32532)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Botanical Biopesticides & Plant Extracts (Essential Oils, Neem, Pyrethrins) (AFABAEAF)
Keywords
Where Eden Research plc is headquartered
LocationHeadquarters
- HQ city
- Cirencester
- HQ country
- United Kingdom
- HQ region
- Europe
Offices3 records
Markets served
Eden Research plc business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Product Sales: Direct sales of formulated biopesticide products (Mevalone, Cedroz) through distribution partners. Revenue from product sales doubled to £1.6m in 2018 from £0.8m in 2017. Majority of revenue now comes from product sales.
- Royalties: Royalty income from licensees using Eden's technology and active ingredients. First commercial launch of products using Eden IP in 2014 by TerpeneTech generated ongoing royalty streams. Royalty income expected to grow as more licensees bring products to market.
- Upfront and Milestone Payments: Payments from commercial partners upon signing agreements, regulatory approvals, and achievement of development milestones. Examples include €0.6m from Sipcam for evaluation agreement, €0.9m option exercise fee from Sipcam, and €0.25m fee from UMMS amendment.
- Data Access Licensing: Licensing access to EU regulatory data and dossiers to third parties such as Daymsa, enabling them to register products using Eden's approved active substances. Generates upfront payments and milestone payments.
Go-to-market motion1 record
Distribution channels10 records
Marketing channels7 records
Eden Research plc product offering
Product offeringCore offering
Eden Research plc develops and commercializes biopesticide formulations based on naturally occurring plant-derived terpenes (thymol, eugenol, geraniol) encapsulated using its proprietary Sustaine microencapsulation technology. The company sells formulated crop protection products (Mevalone biofungicide, Cedroz bionematicide, Novellus+, Ecovelex bird repellent) through exclusive distribution and licensing partners globally, and also licenses its encapsulation technology and regulatory data to third parties.
Product overview
Eden Research plc is a biopesticide and encapsulation technology company that offers a portfolio of sustainable crop protection products and natural microencapsulation technology services. The core product portfolio includes Mevalone (a terpene-based biofungicide for botrytis and powdery mildew control), Cedroz (a bio-nematicide for nematode control), Novellus+ (an enhanced fungicide formulation), and Ecovelex (a bird repellent seed treatment). These products are complemented by Eden's proprietary Sustaine microencapsulation technology platform, which enables the controlled release of natural plant defense metabolites (terpenes) for agricultural and non-agricultural applications. The company also develops animal health products (shampoos, skin treatments, flea/tick control) and consumer products (head-lice treatments, deodorants, fragrances) through licensing partnerships.
Differentiator
Problem solved
Functional benefit
Brands
- Mevalone: Terpene-based biofungicide for prevention and treatment of botrytis (grey mould) on grapes and other high-value crops
- Cedroz
- Novellus+
- Ecovelex
- Sustaine
- GO-E Inside
Products and services
- Mevalone A terpene-based biofungicide for the prevention and treatment of botrytis (grey mould) and powdery mildew on grapes, fruits, and vegetables. Uses Eden's Sustaine microencapsulation technology for controlled release of active ingredients. Sold under various brand names (Mevalone, 3logy, Araw, Hawk, Novellus, Evelta) by distribution partners across territories.
- Cedroz A bio-nematicide formulation for controlling plant parasitic nematodes in both open field and greenhouse horticulture. Contains thymol and geraniol encapsulated using Eden's Sustaine system. Marketed by Eastman Chemical in 29 countries.
- Novellus+ An enhanced version of Mevalone, a terpene-based biofungicide for use on grapes and other high-value crops to control grey mould (botrytis) and powdery mildew. Offers sustainable solutions meeting export standards.
- Ecovelex A bird repellent seed treatment for maize and other crops. Plant-based alternative to banned chemical treatments that deters birds through unpleasant taste or smell without harming wildlife.
- Sustaine Microencapsulation Technology Patented natural plastic-free microencapsulation technology using yeast cells to deliver slow release of natural compounds. Licensed to third parties for use in agricultural and non-agricultural applications.
- Animal Health Products Products for animal health applications including shampoos, conditioners, skin disease control, odour control, and flea and tick control for companion animals. Developed through licensing partnerships.
- Consumer Products Consumer products including head-lice treatments, deodorants, odour neutralisers, and fragrances developed using Eden's encapsulation technology. Licensed to TerpeneTech.
Quantifiable outcome
- Botrytis causes 20% average harvest losses costing €10-100 billion annually worldwide. Market for Botryticides alone exceeds $350 million per annum.
- +3 more outcomes
Companies that use Eden Research plc
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
Eden Research plc technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Eden Research plc partnerships and signals
Strategic signalPartnerships
14 partnerships are on record, tiered minor, major and core.
- Sipcam Chile SpAminorExclusive distributor for Novellus+ in Chile for wine and table grapes to control grey mould and powdery mildew. First approval in South America. Chile is fourth-largest wine exporter globally and a major agricultural market with biological crop protection projected to grow from $735m (2022) to over $834m by 2027.
- SyngentamajorDecember 2025 distribution agreement for ornamental crops (cut flowers, pot plants, trees, shrubs, bulbs) in EU and UK. Product branded as Evelta. First commercial agreement with a major global crop protection company, marking significant validation of Eden's technology.
- Royal Holloway, University of LondoncoreKnowledge Transfer Partnership (KTP) accelerating Ecovelex development. Explores application to new cereal and vegetable seeds building on maize success. Supported by Innovate UK. Brings academic expertise in seed biology and technology with dedicated seed research scientist joining R&D team.
- Véto-pharmaminorSupply agreement for thymol (one of Eden's core active ingredients) for use in bee care products. Thymol valued for antimicrobial and antifungal properties. Agreement marks important development in protection of bee populations.
- Andermatt KenyaminorExclusive distribution partner for Mevalone in Kenya. Part of Swiss-based Andermatt Group specializing in biological crop protection. Regulatory approval already in place for high-value fruit, vegetable, and ornamental crop sectors.
- Advan Mexico (Sipcam-Oxon)minorExclusive distributor for Novellus+ in Mexico following regulatory approval for botrytis on fruit and vegetable crops. Enhanced version of Mevalone offers sustainable solution meeting high standards required for US export.
- Sumi Agro EuropeminorExclusive distributor for Mevalone in Austria, expanding existing partnership across Central Europe. Regulatory approval submitted for grapes and apples. Austria's organic viticulture sector has over 15% certified organic vineyards.
- Sipcam SpA / Sipcam-Oxon GroupcoreMultiple commercial agreements including Evaluation and Option Agreement (€0.6m fee), Collaboration Agreement, and distribution agreements. Sipcam invested £2.2m for 9.9% stake in Eden. Appointed exclusive distributor for Mevalone in Italy, Spain, USA, China, Brazil, Japan, Argentina, Chile, Mexico, South Africa, Australia, New Zealand. Sipcam has right to appoint board director while holding minimum 7.5% stake.
- Bayer Animal HealthcoreDevelopment and launch of animal health products for US market. Multiple products developed with three initial products planned for launch. Launch delayed due to additional formulation work required on one product. Launch expected 2019.
- University of Massachusetts Medical School (UMMS)coreLicence agreement for next-generation encapsulation technology. Original agreement signed 2011 with £570k accrued minimum royalties. June 2017 amendment reset terms with $250k fee, net reduction in short-term obligations. Ongoing collaboration focused on further development.
- Eastman Chemical CompanycoreExclusive distribution agreement for Cedroz nematicide in 29 countries. Eastman submitted regulatory dossiers in Israel, Europe, and Mexico for fruit and vegetable farming. First sales expected 2019/2020. Cedroz is water-based formulation of thymol and geraniol encapsulated using Eden's Sustaine system.
- Taminco BVBAminorExclusive evaluation agreement for nematicide product (B2Y) for crop protection uses. Belgian speciality chemicals company evaluating Eden's nematicide for potential global licensing arrangement to commercialize alongside their existing soil fumigant business. Market worth $1 billion per year.
- TerpeneTech LimitedcoreLicence agreement for use of encapsulation technology in consumer and agricultural biocides. First commercial products launched in France (YP Odor Control pet products). Associate company (equity accounted). Also developed head-lice product approved in EEA in 2018 and under-arm deodorant.
- K&N Efthymiadis S.A. (KNE)coreLong-standing licence agreement since 2006 for botrytis treatment products in Greece and Balkan states. Now distributing Mevalone/Ecovelex across Greece, Serbia, Portugal, and other territories. Successfully conducted pre-launch trials in Greece.
Scale indicators8 records
Recent moves10 records
Expansion highlights6 records
Eden Research plc competitors and assessment
Company assessmentDirect peers
- BioWorks Inc. US biopesticide and biostimulant manufacturer (BotryStop, RootShield). Comparable mid-sized specialty biological inputs business targeting horticulture and specialty crops similar to Eden's core markets.
- Koppert Biological Systems: Dutch global leader in biological crop protection (pollinators, natural enemies, microbials). Directly comparable to Eden as a specialist in sustainable agricultural biocontrol and biopesticide solutions competing for the same grower/bio-input budget.
- Certis Biologicals: Major US/global biopesticide company offering biofungicides, bionematicides, and bioinsecticides. Direct competitor to Eden's Mevalone/Cedroz, particularly in fruit, vegetables, and row crops.
- AgBiTech: Specialist in microbial biopesticides (e.g., baculoviruses). Comparable to Eden as a focused biological crop protection developer with regulatory-heavy, partner-distributed commercial model.
- Valent BioSciences: Sumitomo Chemical-owned biopesticide company and a leading global producer of microbial and biochemical crop protection products. Direct competitor in biofungicides/bionematicides with substantially greater global footprint.
- BioFirst Group: Belgian biological crop protection specialist with macrobiological and microbiological products. Comparable to Eden as a focused biologicals company targeting high-value fruit and vegetable growers via partner networks.
- Marrone Bio Innovations (now BioLargo AFE): US-listed biopesticide developer of biofungicides, bionematicides, and biostimulants (Regalia, Bio-Tam, Venerate). Closely comparable to Eden in scale, scope, and route-to-market via distribution partners.
Broad incumbents
- Syngenta Group: Global crop protection leader (now under Sinochem) and Eden's December 2025 distribution partner. Operates broadly in conventional chemistry and expanding biologicals; overlaps with Eden at the product category level but dwarfs it in scale and product breadth.
- Bayer Crop Science: Largest crop protection and seeds company globally, with a growing biologicals portfolio (Bayer Animal Health partner to Eden). Overlaps with Eden through pest/disease control, but at vastly greater scale and across much broader product portfolio.
- BASF Agricultural Solutions: Global crop protection and seed major; comparable to Eden only loosely, but relevant as an incumbent actively investing in biological and natural-based crop protection as part of its mainstream portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Eden Research plc social profiles
Digital presenceEden Research plc compliance and trust
Trust signalCompliance1 record
Eden Research plc financial estimates
Financial estimateRevenue estimate
Valuation estimate
Eden Research plc leadership team
Management profileNumber of profiles
Profiles6 records
Eden Research plc subsidiaries and ownership
Company hierarchySubsidiaries1 record
Eden Research plc funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Eden Research plc M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Eden Research plc
What does Eden Research plc do?
Eden Research plc develops and commercializes biopesticide formulations based on naturally occurring plant-derived terpenes (thymol, eugenol, geraniol) encapsulated using its proprietary Sustaine microencapsulation technology. The company sells formulated crop protection products (Mevalone biofungicide, Cedroz bionematicide, Novellus+, Ecovelex bird repellent) through exclusive distribution and licensing partners globally, and also licenses its encapsulation technology and regulatory data to third parties.
Is Eden Research plc a public or private company?
Eden Research plc is a public company. It is classified as public and is currently operating.
When was Eden Research plc founded?
Eden Research plc was founded in 2012. It employs 11 to 50 people.
Where is Eden Research plc based?
Eden Research plc is headquartered in Cirencester, United Kingdom, in the Europe region.
How does Eden Research plc make money?
Four revenue lines are on record. Product Sales are the primary driver. The others are royalties, upfront and Milestone Payments and data Access Licensing.
Who are Eden Research plc's main competitors?
Direct peers on record are BioWorks Inc., Koppert Biological Systems, Certis Biologicals, AgBiTech, Valent BioSciences, BioFirst Group and Marrone Bio Innovations (now BioLargo AFE). Broad incumbents are Syngenta Group, Bayer Crop Science and BASF Agricultural Solutions.
Does Eden Research plc have an API?
No public API is recorded for Eden Research plc.
What industry is Eden Research plc in?
Eden Research plc's product category is Biopesticides and Crop Protection. Its primary akta.pro industry code is AFABAEAF, Botanical Biopesticides & Plant Extracts (Essential Oils, Neem, Pyrethrins). Its NAICS code is 32532 and its SIC code is 2833.